ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
First Trust Rising Dividend Achievers

First Trust Rising Dividend Achievers (RDVY)

59.40
0.47
( 0.80% )
Actualizado: 11:23:22

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
59.40
Postura de Compra
59.39
Postura de Venta
59.40
Volume Operado de la Acción
320,758
58.64 Rango del Día 59.48
49.60 Rango de 52 semanas 64.63
Capitalización de Mercado [m]
Precio Anterior
58.93
Precio de Apertura
58.64
Última hora de negociación
11:23:22
Volumen financiero
US$ 19,000,128
Precio Promedio Ponderado
59.2351
Volumen promedio (3 m)
761,237
Acciones en circulación
204,250,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
4.57
Beneficio por acción (BPA)
13
turnover
237.13M
Beneficio neto
2.66B

Acerca de First Trust Rising Dividend Achievers

The investment seeks investment results that correspond generally to the price and yield before fees and expenses of the NASDAQ US Rising Dividend Achievers Index. The fund will normally invest at least 90% of its net assets including investment borrowings in the common stock and depositary receipts... The investment seeks investment results that correspond generally to the price and yield before fees and expenses of the NASDAQ US Rising Dividend Achievers Index. The fund will normally invest at least 90% of its net assets including investment borrowings in the common stock and depositary receipts that comprise the index. The index is designed to provide access to a diversified portfolio of small mid and large capitalization companies with a history of raising their dividends while exhibiting the characteristics to continue to do so in the future by including companies with strong cash balances low debt and increasing earnings. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stock and depositary receipts that comprise the index. Mostrar más

Sector
Mgmt Invt Offices, Open-end
Industria
Mgmt Invt Offices, Open-end
Sede
Boston, Massachusetts, USA
Fundado
-
First Trust Rising Dividend Achievers is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker RDVY. The last closing price for First Trust Rising Divid... was US$58.93. Over the last year, First Trust Rising Divid... shares have traded in a share price range of US$ 49.60 to US$ 64.63.

First Trust Rising Divid... currently has 204,250,000 shares in issue. The market capitalisation of First Trust Rising Divid... is US$12.04 billion. First Trust Rising Divid... has a price to earnings ratio (PE ratio) of 4.57.

RDVY Últimas noticias

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 138 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 135 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 102 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 127 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 124 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.68-1.1318242343560.0860.75558.6485541559.64144103SP
4-1.98-3.2258064516161.3861.566458.2593238659.56215865SP
12-1.17-1.9316493313560.5764.6358.2576123761.16522455SP
262.794.9284578696356.6164.6352.7871841159.29632242SP
528.8317.460945224450.5764.6349.673017456.44651153SP
1566.4912.266112266152.9164.6338.3488776848.97078402SP
26023.2764.406310545336.1364.6321.3378898547.14162841SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PHIOPhio Pharmaceuticals Corporation
US$ 7.12
(321.30%)
215.05M
SLRXSalarius Pharmaceuticals Inc
US$ 4.20
(168.37%)
102.54M
XXII22nd Century Group Inc
US$ 9.31
(90.39%)
14.41M
ATPCAgape ATP Corporation
US$ 2.3201
(84.13%)
68.06M
VRMEVerifyMe Inc
US$ 4.6737
(83.28%)
28.41M
EHGOEshallgo Inc
US$ 1.30
(-60.24%)
2.41M
CMTLComtech Telecommunications Corporation
US$ 1.9901
(-51.81%)
2.92M
NAYANAYA Biosciences Inc
US$ 0.4901
(-39.75%)
727.67k
SVMHSRIVARU Holding Ltd
US$ 0.03805
(-38.43%)
126.73M
TCTMTCTM Kids IT Education Inc
US$ 0.4541
(-38.18%)
750.09k
GCTKGlucoTrack Inc
US$ 0.144001
(23.08%)
596.35M
PHIOPhio Pharmaceuticals Corporation
US$ 7.14
(322.49%)
215.05M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.06325
(-28.21%)
141.5M
SVMHSRIVARU Holding Ltd
US$ 0.03805
(-38.43%)
126.73M
NVDANVIDIA Corporation
US$ 131.9205
(-2.94%)
121.6M
wadirum1 wadirum1 14 segundos hace
The audit has apparently taken about 10 years longer than expected, no?

Is there some point at which we should all just confront Eric on his BS? Or do you think it is for the best to just continue as if the decade of missed deadlines was all just some random sequence of events that
HHSE
Hosai Hosai 22 segundos hace
Even if you read it as needing another trial which is obv up for debate (also would be for FDA - EMA clearly not), it would still mean Anavex have better and more robust long term trial data (3-4 years) compared to any AD phase 2 previously done by a company.
Eli Lily jumped $15.3 billion (
AVXL
BarrellofHay BarrellofHay 32 segundos hace
Company alluded to a Phase 4.

"A phase 4 clinical trial, also known as a post-marketing surveillance trial, is a study that examines a drug's safety and effectiveness after it has been approved and is available for patients."

Key is that this is a study used afte
AVXL
gp22 gp22 36 segundos hace
$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.
MITQ
BottomBounce BottomBounce 37 segundos hace
$NIO Book Value Per Share (mrq) $12.43 Total Cash (mrq) $36.27B
NIO
I-Glow I-Glow 51 segundos hace
That is why you are underwater on Spooz because you believe anything Spooz posts on X as true and factual. LOLOL!

Spooz
@SpoozInc
2h
$SPZI The increase in the Authorized Shares is to secure potential acquisitions and to support the culmination of the commodity and
SPZI
gp22 gp22 54 segundos hace
$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.
MITQ
Hi_Lo Hi_Lo 1 minuto hace
You haven't stopped anything and you never will
I'm not trying to stop anything. Unlike you and your lying pumps that helps and furthers this scam, I'm simply warning people here with documentation that this is a scam and that Jake P. Noch has a history of perpetrating huge frauds - including
BCAP
Strukture Strukture 1 minuto hace
VRME for the win today!
VRME
doc2016 doc2016 2 minutos hace
emPath ....thinking nvidia now hiring asic engineers in taiwan. i wonder why china wants more influence in taiwan? asics and fpga; asics and memristors, which remembering em state can go to tha switching /gate position..with soft fabric and software stacks and api's with the emPath information....
IONQ
martyDg martyDg 2 minutos hace
If I were a betting person, I would bet that mRESVIA and DCVax-L will be among the drugs that are approved by MHRA in January.


Who's going tell him he's about to be wrong? Maybe, try February, March, April and so on. 😝
NWBO
Zorax Zorax 2 minutos hace
Trying wash trading to look like interest again? Lots of beneficial ownership shenanigans as usual. Tax write offs anyone?
UEEC
scortech scortech 2 minutos hace
I doubt same "Person". Buys are making MM's buy their shorts back
Did good slap an ask they'll lose their shorts and show their A$$
JMO.
CGAC
Investor2014 Investor2014 2 minutos hace
The ability of Anavex snatching defeat from the claws of victory is uncanny!
AVXL
BCCHoosier BCCHoosier 2 minutos hace
Spot on. We have used a few bullets already and going nowhere. If we do get bought out it will be for far less than any of us expected.
AVXL
jpike jpike 2 minutos hace
I now have the largest position in Pays that I have held in years. Looking forward to large gains in the next year or two on this one.
PAYS
peanutz peanutz 2 minutos hace
If you are depending on that it's ashame . You are in the wrong business.
IGPK
hedge_fun hedge_fun 3 minutos hace
Jeff if you recall, there was a promo…….

group that talked about the OS reduction through a Preferred offering about 2 years ago. It was when the pps ran up to around half a penny.

Then they dumped and stopped pumping.

But they mentioned it in a podcast
APRU
arachnodude arachnodude 3 minutos hace
You asked...

How many trolls like Slinger spend their days obsessively spreading cherry-picked, manipulated nonsense, ignoring facts, and attacking progress just to get a rise out of others? Unfortunately, the answer to that is: far too many.

🤣🤣🤣
KBLB
Zenos Arrow Zenos Arrow 3 minutos hace
I’m sure he’s still there Loc. Why would he leave – he’s still getting paid? The bigger question is, has he done enough to satisfy his six-month incentive metrics. If so, we should get an 8-K announcing that 500K more shares were granted via meeting these metrics. So, no communication forthcoming co
HDVY
Gator44 Gator44 3 minutos hace
https://ih.advfn.com/stock-market/NASDAQ/sana-biotechnology-SANA/stock-news/95237254/form-8-k-current-report
SANA
Mojocash Mojocash 3 minutos hace
Averaged down for a rainy day!
HLLK
linkvest linkvest 3 minutos hace
Eat those freakin awesome 5s up newbies. They are so cheap for a quality company that has so much on the horizon and about to explode any time now.
ASII
zab zab 4 minutos hace
https://www.yahoo.com/news/maga-republican-slammed-saying-california-003138819.html

Once again, Republicans from California, let's not pay for anything.